Literature DB >> 21905279

Treatment with Astragalus membranaceus produces antioxidative effects and attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in rats.

Rongfa Chen1, Hua Shao, Shiqing Lin, Jin-Jun Zhang, Kang-Qing Xu.   

Abstract

Astragalus membranaceus, also known as huang qi, a traditional Chinese medicine, is often used in formulas for deficiency of vital energy characterized by limb weakness, pale face, and dizziness. Previous studies have shown that Astragalus membranaceus could attenuate intestinal ischemia-reperfusion injury induced by hemorrhagic shock in rats; however, the underlying mechanism still remains unclear. Using a hemorrhagic shock rat model to examine the effect of Astragalus membranaceus on intestinal mucosa injury induced by ischemia-reperfusion, we found that treatment (20 g crude drugs/kg, i.v.) produced antioxidative effects in the intestinal mucosa of rats after ischemia-reperfusion (p < 0.05). We also found that Astragalus membranaceus could partly attenuate intestinal mucosa ischemia-reperfusion injury (chiu's score, apoptosis index p < 0.05). These results suggest that Astragalus membranaceus reduces intestinal mucosa injury induced by ischemia-reperfusion in rats, at least in part, through its anti-oxidative effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21905279     DOI: 10.1142/S0192415X11009275

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  11 in total

1.  Astragaloside IV and echinacoside benefit neuronal properties via direct effects and through upregulation of SOD1 astrocyte function in vitro.

Authors:  Yang Tian; Shijie Jin; Vanessa Promes; Xuemei Liu; Yunling Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-20       Impact factor: 3.000

2.  Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells.

Authors:  Weiwei Qi; Jianying Niu; Qiaojing Qin; Zhongdong Qiao; Yong Gu
Journal:  Cell Stress Chaperones       Date:  2013-05-30       Impact factor: 3.667

3.  Mitochondrial protection and anti-aging activity of Astragalus polysaccharides and their potential mechanism.

Authors:  Xing-Tai Li; Ya-Kui Zhang; Hai-Xue Kuang; Feng-Xin Jin; De-Wen Liu; Ming-Bo Gao; Ze Liu; Xiao-Juan Xin
Journal:  Int J Mol Sci       Date:  2012-02-07       Impact factor: 6.208

4.  Screening SIRT1 Activators from Medicinal Plants as Bioactive Compounds against Oxidative Damage in Mitochondrial Function.

Authors:  Yi Wang; Xinying Liang; Yaqi Chen; Xiaoping Zhao
Journal:  Oxid Med Cell Longev       Date:  2016-02-11       Impact factor: 6.543

5.  Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response.

Authors:  Simona Adesso; Rosario Russo; Andrea Quaroni; Giuseppina Autore; Stefania Marzocco
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

6.  Integrated Chinese and Western Medicine for Acute Guillain-barré Syndrome Treatment.

Authors:  Liu Yang; Xiumin Zhao
Journal:  Transl Neurosci       Date:  2020-02-29       Impact factor: 1.757

7.  Antioxidant and anti-inflammatory effects of Astragalus polysaccharide on EA.hy926 cells.

Authors:  Wei Min Huang; Yong Qi Liang; Li Jun Tang; Yue Ding; Xiao Hong Wang
Journal:  Exp Ther Med       Date:  2013-04-23       Impact factor: 2.447

8.  Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction.

Authors:  Jun Xiao; Song-Bai Deng; Qiang She; Jun Li; Guo-Ying Kao; Jun-Sheng Wang; Y U Ma
Journal:  Exp Ther Med       Date:  2015-09-22       Impact factor: 2.447

9.  Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth.

Authors:  Chengying Gu; Yipeng Zeng; Zhaosheng Tang; Chaoxun Wang; Yanju He; Xinge Feng; Ligang Zhou
Journal:  Mol Med Rep       Date:  2015-08-25       Impact factor: 2.952

10.  A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy.

Authors:  Zhiyuan Deng; Manjia Wang; Yao-Hua Fan; Ruilin Huang; Yawen Rao; Xurong Mai; Min Liu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.